Quantexa Secures £135.5m in Series F Funding for AI Expansion

Deal News | Mar 07, 2025 | UK Tech Funding

Quantexa Secures £135.5m in Series F Funding for AI Expansion

In a notable week for UK tech funding, significant investments were tracked across several innovative companies, totaling £200.3 million—an impressive 110% increase from the previous week. Quantexa, a leading AI data intelligence platform with a London headquarters, raised £135.5 million in a Series F funding round. The round was led by a consortium including HSBC, Warburg Pincus, and Ontario Teachers Pension Plan, among others. Quantexa’s Decision Intelligence platform aims to integrate disparate data to resolve complex data management challenges. Meanwhile, Cambridge-based Trimtech Therapeutics, operating in health tech, secured £25 million in a seed round with investments from key players such as Cambridge Innovation Capital and Pfizer Ventures.

Sectors

  • Artificial Intelligence
  • Health Technology

Geography

  • United Kingdom – The article focuses on UK-based tech companies and their investment activities.

Industry

  • Artificial Intelligence – Quantexa operates within the AI sector, developing platforms for data intelligence and decision-making.
  • Health Technology – Trimtech Therapeutics is part of the health tech industry, focusing on innovative medical solutions.

Financials

  • 200.3m – Total worth of UK tech investment tracked during the week.
  • 135.5m – Amount raised by Quantexa in their Series F funding round.
  • 25m – Amount raised by Trimtech Therapeutics in their seed funding round.

Participants

NameRoleTypeDescription
QuantexaTarget CompanyCompanyA London-based AI data intelligence platform developer.
Trimtech TherapeuticsTarget CompanyCompanyA health tech startup based in Cambridge focusing on therapeutic solutions.
Warburg PincusInvestorCompanyA private equity firm involved in Quantexa's Series F funding round.
HSBCInvestorCompanyA global banking corporation that invested in Quantexa.
Ontario Teachers Pension PlanInvestorCompanyA major investor in Quantexa’s funding round.
Cambridge Innovation CapitalInvestorCompanyAn investor in Trimtech Therapeutics' seed round.
Pfizer VenturesInvestorCompanyAn investment arm of Pfizer, involved in Trimtech Therapeutics’ funding.